← FDA Drug Approvals (Drugs@FDA)

FOSAPREPITANT DIMEGLUMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: QILU PHARM HAINAN · Approved 2020-09-08

Drug application

FDA Application #

ANDA213106

Application type

Abbreviated New Drug Application (Generic)

Brand name

FOSAPREPITANT DIMEGLUMINE

Generic name

FOSAPREPITANT DIMEGLUMINE

Active ingredients

FOSAPREPITANT DIMEGLUMINE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

QILU PHARM HAINAN

Manufacturer

Hikma Pharmaceuticals USA Inc.

First approval

2020-09-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown